NASH and insulin resistance: Insulin hypersecretion and specific association with the insulin resistance syndrome

Hepatology

Volumn 35, Issue 2, 2002, Pages 373-379

  Chitturi, Shivakumar ^a   Abeygunasekera, Shehan ^b   Farrell, Geoffrey C ^a   Holmes Walker, Jane ^c   Hui, Jason M ^a   Fung, Caroline ^c   Karim, Rooshdiya ^a   Lin, Rita ^a   Samarasinghe, Dev ^a   Liddle, Christopher ^a   Weltman, Martin ^b   George, Jacob ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

^b NEPEAN HOSPITAL   (Australia)

^c WESTMEAD HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

C PEPTIDE; GLUCOSE; INSULIN; LIPID;

ADULT; ARTICLE; BODY MASS; DISEASE ASSOCIATION; DISEASE SEVERITY; FATTY LIVER; FEMALE; GLUCOSE BLOOD LEVEL; HEPATITIS; HEPATITIS C VIRUS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYPERINSULINEMIA; INSULIN BLOOD LEVEL; INSULIN RELEASE; INSULIN RESISTANCE; LIPID BLOOD LEVEL; LIVER FIBROSIS; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PREVALENCE; PRIORITY JOURNAL; SYNDROME; WORLD HEALTH ORGANIZATION;

EID: 18244364864     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1053/jhep.2002.30692     Document Type: Article

References (42)

1. Nonalcoholic steatohepatitis. Mayo Clinic experiences with a hitherto unnamed disease
2. Nonalcoholic fatty liver disease: A spectrum of clinical and pathological severity
3. Etiopathogenesis of nonalcoholic steatohepatitis
4. The natural history of nonalcoholic steatohepatitis: A follow-up study of 42 patients for up to 21 yeats
5. Hepatocyte cytochrome P450 2E1 is increased in patients with nonalcoholic steatohepatitis
6. Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis
7. Fatty liver hepatitis (steatohepatitis) and obesity: An autopsy study with analysis of risk factors
8. Nonalcoholic steatohepatitis (NASH): A disease of emerging identity and importance
9. Non-alcoholic fatty liver: Another feature of the metabolic syndrome?
10. Non-alcoholic steatohepatitis: Impaired antipyrine metabolism and hypertriglyceridaemia may be clues to its pathogenesis
11. Role of insulin resistance in human disease
12. Prospective analysis of the insulin-resistance syndrome (syndrome X)
13. Syndrome X: 6 Years later
14. Severe insulin resistance syndromes and nonalcoholic steatohepatitis
15. Homeostasis model assessment: Insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man
16. Nonalcoholic steatohepatitis: A proposal for grading and staging the histological lesions
17. Guidelines for healthy weight
18. The Asia-Pacific perspective: Redefining obesity and its treatment
19. Classification of chronic viral hepatitis: A need for reassessment
20. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge
21. Clinical practice recommendations 2000
22. Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity: Studies in subjects with various degrees of glucose tolerance and insulin sensitivity
23. Comment on the provisional report from the WHO consultation
24. Pathogenesis of glucose intolerance and diabetes mellitus in cirrhosis
25. Glucose intolerance and insulin resistance in cirrhosis are normalized after liver transplantation
26. Liver pathology and the metabolic syndrome X in severe obesity
27. Nonalcoholic steatohepatitis in children
28. The pathology of non-alcoholic steatohepatitis (NASH): A working definition and recommendations for evaluation of NASH pathology in clinical studies
29. Prevalence of insulin resistance in metabolic disorders: The Bruneck Study
30. Nonalcoholic steatohepatitis: Association of insulin resistance and mitochondrial abnormalities
31. Insulin resistance in non-alcoholic steatohepatitis
32. Nonalcoholic fatty liver disease: A feature of the metabolic syndrome
33. Association of nonalcoholic fatty liver disease with insulin resistance
34. Hyperinsulinemia and insulin resistance in non-alcoholic steatohepatitis
35. Fatty liver - An additional and treatable feature of the insulin resistance syndrome
36. Insulin regulation of regional free fatty acid metabolism
37. The metabolically obese, normal-weight individual revisited
38. Nonalcoholic steatohepatitis: An expanded clinical entity
39. Further evidence for an association between non-insulin-dependent diabetes mellitus and chronic hepatitis C virus infection
40. Risk factors for diabetes mellitus and early insulin resistance in chronic hepatitis C